Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be at least 21 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights
Study Summary
This trial is testing whether a brain-dedicated PET insert for an MR scanner can be used to study the metabolism and perfusion of Covid-19 negative and positive/once positive subjects.
Who is the study for?
This trial is for adults over 21 who've had a low radiation exposure in the past year and are healthy enough for imaging studies. They must have proof of COVID-19 testing done between 20 to 180 days before the scan but can't join if they're pregnant, nursing, allergic to PET radiotracers, or have non-MRI safe surgeries or implants.Check my eligibility
What is being tested?
The study tests a new brain-focused PET insert used inside an MR scanner on people with and without past COVID-19 infection. It aims to create protocols for simultaneous PET/MR images that show both brain function (metabolism/perfusion) and structure.See study design
What are the potential side effects?
Potential side effects may include reactions related to the injected radiotracer such as discomfort at injection site or allergic reactions, although specific side effects are not detailed in this summary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 21 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PET/MR
Trial Design
2Treatment groups
Experimental Treatment
Group I: Covid-19 Positive/Infected PopulationExperimental Treatment1 Intervention
5 participants will be recruited, injected with radiopharmaceutical, and imaged on the 3T PETMR with PET insert.
Group II: Covid-19 Negative/Uninfected PopulationExperimental Treatment1 Intervention
5 participants will be recruited, injected with radiopharmaceutical, and imaged on the 3T PETMR with PET insert.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,340 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The study lead has confirmed I'm healthy enough for the imaging study.You have received less than 5000 mrem of radiation in the past year, as reported by you.I am 21 years old or older.I have had surgeries or implants that are not safe for MRI.You have had allergic reactions to PET radiotracers in the past.You need to have had a COVID-19 test between 20 and 180 days before the scan.
Research Study Groups:
This trial has the following groups:- Group 1: Covid-19 Negative/Uninfected Population
- Group 2: Covid-19 Positive/Infected Population
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for enrolment in this experiment?
"Yes, according to the data presented on clinicaltrials.gov this medical study is still enrolling patients for participation; it was initially posted on July 1st 2022 and amended most recently on October 3rd 2022. Currently, only 10 participants are required from a single site."
Answered by AI
What is the total capacity of participants for this trial?
"Affirmative. Clinicaltrials.gov data reveals that this medical trial is open to recruiting, and was originally posted on July 1st 2022 with a most recent update made on October 3rd 2022. The study needs 10 patients from a single centre for participation."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger